Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
ICH accounts for approximately 15 percent of all strokes. Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50...
What do you do for the patient in cardiogenic shock who is not responding to vasopressors and inotropes? Should you place a mechanical circulatory...
To say that 2020 has been a challenging year would be a gross understatement. The courage and determination that all healthcare providers have shown...
